A nurse is preparing to administer digoxin 1 mg PO to a client. The amount available is digoxin 0.5 mg/tablet.

How many tablets should the nurse administer? (Round to the nearest whole number. Use a leading zero if it applies.

(Do not use a trailing zero)

Choice A rationale
High fever in the early morning is not a typical finding in pulmonary tuberculosis. TB patients may experience low-grade fevers, but high fevers are less common and usually occur in the evening or at night.
Choice B rationale
Fatigue is a common symptom of pulmonary tuberculosis. TB is a chronic infectious disease that can cause prolonged periods of fatigue and weakness due to the body’s ongoing immune response to the infection.
Choice C rationale

Increased appetite is not a typical finding in pulmonary tuberculosis. TB patients often experience a loss of appetite and unintentional weight loss due to the systemic effects of the infection.
Choice D rationale
Night sweats are a classic symptom of pulmonary tuberculosis. TB patients often experience drenching night sweats as a result of the body’s immune response to the infection. This symptom, along with chronic cough and weight loss, is a key indicator of TB.

Choice A rationale
Regular insulin is correct because it is a short-acting insulin that can be used to treat diabetic ketoacidosis (DKA). The client’s symptoms of confusion, flushed appearance, and acetone odor on the breath suggest DKA, which requires prompt treatment with insulin to lower blood glucose levels and correct metabolic acidosis. Regular insulin has a rapid onset of action and can be administered intravenously to achieve quick results.
Choice B rationale
NPH insulin is incorrect because it is an intermediate-acting insulin that is not suitable for the immediate treatment of DKA. NPH insulin has a slower onset of action and is typically used for

basal insulin coverage rather than for acute management of hyperglycemia. In cases of DKA, rapid-acting or short-acting insulin is preferred to achieve quick glucose control.
Choice C rationale
Glargine insulin is incorrect because it is a long-acting insulin that provides basal insulin coverage over 24 hours. It is not suitable for the immediate treatment of DKA, as it does not have a rapid onset of action. Glargine insulin is typically used for maintaining stable blood glucose levels over a prolonged period rather than for acute management of hyperglycemia.
Choice D rationale
Detemir insulin is incorrect because it is a long-acting insulin similar to glargine. It provides basal insulin coverage and is not suitable for the immediate treatment of DKA. Detemir insulin has a slower onset of action and is used for maintaining stable blood glucose levels rather than for rapid correction of hyperglycemia in acute situations.